Navigation Links
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
Date:7/13/2010

isclosed, will not be sufficient to fund our operations beyond such quarter unless we are able to raise additional capital by selling assets or through external financing;
  • the consent decree between the Company and the FDA and the Company's suspension of the production and shipment of all of the products that it manufactures and the related nationwide recall affecting all of the products that it manufactures, as well as the related material adverse effect on its revenue, assets and liquidity and capital resources, as more fully described in Part I, Item 2 – "Management's Discussion and Analysis of Financial Condition and Results of Operations – Background – Discontinuation of Manufacturing and Distribution; Product Recalls; and the FDA Consent Decree" in the Form 10-Q;
  • the possibility of further reducing the Company's operations, including further reductions of its employee base and significantly curtailing some or all of its efforts to meet the consent decree's requirements and return its approved products to market in order to maintain and attempt to increase its limited cash and financial resources, and related costs and accounting charges from taking such actions;
  • the plea agreement between the Company and the U.S. Department of Justice and the Company's obligations therewith, as well as the related material adverse effect, if any, on its revenue, assets and liquidity and capital resources, as more fully described in Note 20 – "Subsequent Events" of the Notes to the Consolidated Financial Statements in the Form 10-Q;
  • changes in the current and future business environment, including interest rates and capital and consumer spending;
  • the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized;
  • the possibility of not obtaining FDA approvals or delay in obtaining FDA approvals, including with respect to Gestiva™;
  • acceptance of
    '/>"/>

  • SOURCE K-V Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Ferring Pharmaceuticals FIRMAGON® Named Official Sponsor of Ed Randalls Bat for the Cure
    2. Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc.
    3. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
    4. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
    5. K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010
    6. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
    7. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
    8. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
    9. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
    10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
    11. EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
    (Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
    (Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
    Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
    ... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
    ... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
    Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
    (Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Red ... title in a recent online poll at http://scoutology.com/novaburgerwars and was selected as ... be published in August 2015. , Red Hot & Blue President Randy McCann said, ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just ... official kick off of July as National Hot Dog Month. Americans are expected to ... other time of the year and enough to stretch from Washington D.C. to Los ...
    (Date:6/30/2015)... ... June 30, 2015 , ... ... Northwest ENT and Allergy Center . , Dr. Antunes ... eyelid, reconstructive, sinus and ear procedures. In addition to performing cosmetic and reconstructive ...
    (Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood Federation ... today. Why We Care Youth serves as a platform for young people living in ... to them, and why U.S. policymakers should care about expanding access around the world. ...
    (Date:6/30/2015)... ... 2015 , ... NJ Top Dentist, Dr. Susan Goldfarb, had a very busy ... for members of the Bergen County Dental Society. She does this every year ... for Healthcare Providers. Life Support from Hackensack Hospital provided the instructors and she ...
    Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3
    ... may be an independent cause of excessive daytime ... occurrences. Researchers from Sweden performed polysomnography testing on ... years. The apnea-hypopnea index (AHI) was calculated, and ... or very often were considered habitual snorers. Habitual ...
    ... Nov. 11 What would make 100,000 people,stand in ... will be answered November 28, 29 at St. Peter ... in Burlingame on,November 30 when Issam Nemeh, M.D. arrives ... A cardiothoracic anesthesiologist, Dr.,Nemeh has become known as "The ...
    ... DIEGO, Nov. 11 Orthodontists have been,straightening teeth ... action has a reaction," in which tooth displacement ... the other as well. Use of dental implants ... expediting,treatment times and expanding possibilities for previously untreatable,cases, ...
    ... Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, ... ScD, at LSU Health Sciences Center New Orleans School ... most comprehensive assessment of the burden of human papillomavirus ... report, "Assessing the Burden of Human Papillomavirus (HPV)-Associated ...
    ... Philanthropy Day Celebration Honors City,s Exemplary Orgs., ... ... Red Cross of Greater,Los Angeles will be honored as the Outstanding Volunteer ... at the Beverly Hilton Hotel., This award is given annually to ...
    ... from dose-ranging study of new,oral anti-coagulant in patients with ... to begin in December., NEW ORLEANS, Nov. 11 ... anti-clotting agent -- rivaroxaban -- designed to,identify doses that ... efficacy,and safety trials. The results of ATLAS ACS-TIMI 46 ...
    Cached Medicine News:Health News:Journal CHEST: Nov. highlights 2Health News:A New Meaning of Thanksgiving: Miracles for Many, Prayers for All as Healing Services Come to San Francisco 2Health News:Dental Implants Effective for Orthodontic Treatment 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 3Health News:LSUHSC public health contributes to estimate of HPV-related cancers 4Health News:American Red Cross of Greater Los Angeles Named Outstanding Volunteer Organization 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 3Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 4
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Medicine Products: